Painkiller review: Netflix drops the ball in retelling OxyContin story

Painkiller
Micah Fitzerman-Blue and Noah Harpster
Netflix

IN DECEMBER 1995, the prescribed drugs agency Purdue Pharma reached an essential milestone: its new opioid, OxyContin, was authorised by the US Meals and Drug Administration for the remedy of reasonable ache. One key facet of the choice was a single sentence on the drug’s label claiming that its 12-hour delayed absorption was “believed” to cut back the chance of customers changing into hooked on it.

This semantic sidestep is considered one of many tales advised in Painkiller …